Royalty Pharma plc
RPRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001802768
In the last 90 days, Royalty Pharma plc insiders filed 0 open-market purchases and 5 sales; 650 institutions reported holding it in 13F filings for Q2 2026, worth $20.6B in total; Dorsey Asset Management is the only superinvestor holding it.
13F holders, Q3 2021
Institutional positions in Royalty Pharma plc as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 234
- −2 vs. Q2 2021
- Shares held
- 265.4M
- +15.3M (+6.1%) vs. Q2 2021
- Total value
- $9.59B
- −$661.2M (−6.4%) vs. Q2 2021
- New holders
- 36
- 93 more added
- Sold out
- 38
- 79 more reduced
2 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RPRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 650 | $20.6B |
| Q1 2026 | 594 | $17.0B |
| Q4 2025 | 542 | $13.8B |
| Q3 2025 | 490 | $11.6B |
| Q2 2025 | 458 | $12.4B |
| Q1 2025 | 447 | $9.67B |
| Q4 2024 | 417 | $8.21B |
| Q3 2024 | 396 | $8.85B |
| Q2 2024 | 380 | $8.36B |
| Q1 2024 | 381 | $9.49B |
| Q4 2023 | 364 | $8.74B |
| Q3 2023 | 315 | $8.17B |
| Q2 2023 | 327 | $9.33B |
| Q1 2023 | 338 | $10.9B |
| Q4 2022 | 338 | $11.8B |
| Q3 2022 | 320 | $12.0B |
| Q2 2022 | 286 | $12.3B |
| Q1 2022 | 280 | $10.5B |
| Q4 2021 | 267 | $10.7B |
| Q3 2021 | 234 | $9.59B |
| Q2 2021 | 238 | $10.3B |
| Q1 2021 | 216 | $10.7B |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Royalty Pharma plc; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nuveen Asset Management, LLC | 987,535 | $35.7M | 0.01% | −207,347−17.4% | Reduced |
| Eaton Vance Management | 995,868 | $36.1M | 0.05% | −387,205−28.0% | Reduced |
| Bleichroeder LP | 1,115,980 | $40.3M | 6.58% | +915,980+458.0% | Added |
| RE Advisers Corp | 1,157,840 | $41.8M | 1.02% | +437,600+60.8% | Added |
| Marshall Wace, LLP | 1,201,980 | $43.4M | 0.22% | +1,201,980 | New |
| Ameriprise Financial Inc | 1,292,261 | $46.7M | 0.01% | −59,915−4.4% | Reduced |
| Amundi | 1,393,281 | $50.4M | 0.04% | −1,434,984−50.7% | Reduced |
| Legal & General Group Plc | 1,495,030 | $54.0M | 0.02% | +23,793+1.6% | Added |
| General Atlantic LLC | 1,500,000 | $54.2M | 0.32% | 00.0% | Unchanged |
| TimesSquare Capital Management, LLC | 1,520,000 | $54.9M | 0.48% | +18,440+1.2% | Added |
| Suvretta Capital Management, LLC | 1,527,900 | $55.2M | 0.94% | +798,523+109.5% | Added |
| Northern Trust Corp | 1,668,674 | $60.3M | 0.01% | +450,183+36.9% | Added |
| Bank of New York Mellon Corp | 1,702,989 | $61.5M | 0.01% | +709,683+71.4% | Added |
| Standard Life Aberdeen plc | 1,801,145 | $65.1M | 0.15% | −82,866−4.4% | Reduced |
| Bank of America Corp | 1,889,651 | $68.3M | 0.01% | +297,095+18.7% | Added |
| Price T Rowe Associates Inc | 2,196,736 | $79.4M | 0.01% | −3,117−0.1% | Reduced |
| Janus Henderson Group PLC | 2,362,294 | $85.4M | 0.04% | −1,383,120−36.9% | Reduced |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $96.9M | 60.36% | 00.0% | Unchanged |
| Norges Bank | 2,860,730 | $103.4M | 0.02% | +65,778+2.4% | Added |
| Wellington Management Group LLP | 3,128,405 | $113.1M | 0.02% | −1,175,121−27.3% | Reduced |
| Viking Global Investors LPSuperinvestorViking Global Investors | 4,140,508 | $149.6M | 0.41% | +901,854+27.8% | Added |
| Geode Capital Management, LLC | 4,168,049 | $150.5M | 0.02% | +2,183,363+110.0% | Added |
| Capital International Investors | 4,987,467 | $180.2M | 0.04% | −11,955,241−70.6% | Reduced |
| JPMorgan Chase & Co | 5,316,482 | $192.1M | 0.03% | −1,998,519−27.3% | Reduced |
| State Street Corp | 5,834,745 | $210.9M | 0.01% | +967,111+19.9% | Added |
| Siguler Guff Advisers, LLC | 6,761,970 | $244.4M | 79.54% | 00.0% | Unchanged |
| Harvard Management Co Inc | 7,142,856 | $258.1M | 15.13% | 00.0% | Unchanged |
| Vantage Consulting Group Inc | 7,862,542 | $284.2M | 60.85% | −1,439,903−15.5% | Reduced |
| Berkshire Hathaway IncSuperinvestorBerkshire Hathaway | 13,145,902 | $475.1M | 0.16% | +13,145,902 | New |
| BlackRock Inc. | 15,460,845 | $558.8M | 0.02% | +5,173,204+50.3% | Added |
| FMR LLC | 19,109,757 | $690.6M | 0.05% | −4,986,172−20.7% | Reduced |
| Adage Capital Partners GP, L.L.C. | 24,697,815 | $892.6M | 1.76% | +1,976,000+8.7% | Added |
| Vanguard Group Inc | 30,028,062 | $1.09B | 0.03% | +5,685,862+23.4% | Added |
| Morgan Stanley | 57,305,311 | $2.07B | 0.28% | +6,511,270+12.8% | Added |
| Caas Capital Management LP | 0 | $0 | 0.00% | −619,939−100.0% | Sold out |
| Rokos Capital Management LLP | 0 | $0 | 0.00% | −333,778−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −310,887−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −105,724−100.0% | Sold out |
| Twinbeech Capital LP | 0 | $0 | 0.00% | −103,101−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −88,810−100.0% | Sold out |
| Evercore Wealth Management, LLC | 0 | $0 | 0.00% | −83,532−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −54,095−100.0% | Sold out |
| Pinebridge Investments, L.P. | 0 | $0 | 0.00% | −46,701−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −32,027−100.0% | Sold out |
| Sciencast Management LP | 0 | $0 | 0.00% | −21,199−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −19,300−100.0% | Sold out |
| Bridgewater Associates, LP | 0 | $0 | 0.00% | −18,347−100.0% | Sold out |
| FORA Capital, LLC | 0 | $0 | 0.00% | −14,877−100.0% | Sold out |
| Wolverine Asset Management LLC | 0 | $0 | 0.00% | −14,212−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −9,223−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −8,843−100.0% | Sold out |
| Comerica Bank | 0 | $0 | 0.00% | −9,151−100.0% | Sold out |
| Quadrature Capital Ltd | 0 | $0 | 0.00% | −7,700−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −7,440−100.0% | Sold out |
| Alps Advisors Inc | 0 | $0 | 0.00% | −7,232−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −6,668−100.0% | Sold out |
| Ethic Inc. | 0 | $0 | 0.00% | −6,638−100.0% | Sold out |
| Ameritas Investment Company, LLC | 0 | $0 | 0.00% | −5,831−100.0% | Sold out |
| Teza Capital Management LLC | 0 | $0 | 0.00% | −5,461−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −5,377−100.0% | Sold out |
| World Asset Management Inc | 0 | $0 | 0.00% | −5,141−100.0% | Sold out |
| Cedar Brook Financial Partners, LLC | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Xcel Wealth Management, LLC | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| qPULA Trading Management LP | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| PGGM Investments | 0 | $0 | 0.00% | −4,135−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −2,530−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −928−100.0% | Sold out |
| Glassman Wealth Services | 0 | $0 | 0.00% | −599−100.0% | Sold out |
| Fifth Third Bancorp | 0 | $0 | 0.00% | −251−100.0% | Sold out |
| Gemmer Asset Management LLC | 0 | $0 | 0.00% | −145−100.0% | Sold out |
| Vigilant Capital Management, LLC | 0 | $0 | 0.00% | −28−100.0% | Sold out |
| Arcadia Investment Advisors LLC | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Pictet Asset Management Ltd | – | – | – | – | Not filed |
| CWM, LLC | – | – | – | – | Not filed |